Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.
作者： Aikaterini Tsentemeidou , Timoleon-Achilleas Vyzantiadis , Aikaterini Kyriakou , Dimitrios Sotiriadis , Aikaterini Patsatsi
DOI: 10.1111/MYC.12681
关键词:
摘要: Summary Nail psoriasis and onychomycosis can often be hard to differentiate clinically may coexist, complicating each other's course. The aim of this study was determine the prevalence among patients with nail not being treated immunosuppressive agents, which constitute an independent risk factor for fungal infections. A cross-sectional performed. All adult who were receiving antifungal and/or treatment recruited at 2nd University Dermatology Department Aristotle Thessaloniki from 10/2016 till 02/2017. If suspected, samples collected direct microscopy 15% KOH solution culture Target-NAPSI DLQI score also calculated. Of 23 recruited, 20 men 3 women, a mean age 53.43 years (48.25, 58.62), target-NAPSI 10.72 (9.62, 11.77) 10.17 (7.46, 12.89). total 34.78% tested positive onychomycosis. Yeast isolated in 37.50% cases, non-dermatophyte filamentous fungi T. rubrum 12.50%. is higher than that general population Greece (15%-20%). moulds predominate infection cases patients.
sci-hub.se 参考文章(50)
Zeynep Tülay Altunay, Macit Ilkit, Yaşargül Denli, Investigation of tinea pedis and toenail onychomycosis prevalence in patients with psoriasis Mikrobiyoloji Bulteni. ,vol. 43, pp. 439- 447 ,(2009)
Karen Regina Rosso Schons, André Avelino Costa Beber, Maristela de Oliveira Beck, Odirlei André Monticielo, Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features. Anais Brasileiros De Dermatologia. ,vol. 90, pp. 314- 319 ,(2015) , 10.1590/ABD1806-4841.20153736
Federico Bardazzi, Valentina A. Antonucci, Vera Tengattini, Giulia Odorici, Riccardo Balestri, Annalisa Patrizi, A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis. Journal Der Deutschen Dermatologischen Gesellschaft. ,vol. 11, pp. 1065- 1070 ,(2013) , 10.1111/DDG.12173
J.P. Ortonne, C. Paul, E. Berardesca, V. Marino, G. Gallo, Y. Brault, J.M. Germain, A 24‐week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis British Journal of Dermatology. ,vol. 168, pp. 1080- 1087 ,(2013) , 10.1111/BJD.12060
Dimitrios Rigopoulos, Vassilios Katsiboulas, Elma Koumantaki, Penny Emmanouil, Assimina Papanicolaou, Andreas Katsambas, Epidemiology of onychomycosis in southern Greece International Journal of Dermatology. ,vol. 37, pp. 925- 928 ,(1998) , 10.1046/J.1365-4362.1998.00613.X
C. Blome, A. Costanzo, E. Dauden, C. Ferrandiz, G. Girolomoni, R. Gniadecki, L. Iversen, A. Menter, K. Michaelis-Wittern, A. Morita, H. Nakagawa, K. Reich, M. Augustin, Patient-relevant Needs and Treatment Goals in Nail Psoriasis Quality of Life Research. ,vol. 25, pp. 1179- 1188 ,(2016) , 10.1007/S11136-015-1136-Y
L. Zisova, V. Valtchev, E. Sotiriou, D. Gospodinov, G. Mateev, Onychomycosis in patients with psoriasis--a multicentre study. Mycoses. ,vol. 55, pp. 143- 147 ,(2011) , 10.1111/J.1439-0507.2011.02053.X
Avner Shemer, Henri Trau, Batya Davidovici, Marcelo H. Grunwald, Boaz Amichai, Onychomycosis in psoriatic patients – rationalization of systemic treatment Mycoses. ,vol. 53, pp. 340- 343 ,(2009) , 10.1111/J.1439-0507.2009.01726.X
Éva Szepes, Mykotische Infektionen psoriatischer Nägel/Mycotic Infections of Psoriatic Nails Mycoses. ,vol. 29, pp. 82- 84 ,(2009) , 10.1111/J.1439-0507.1986.TB03754.X
V Leibovici, K Hershko, A Ingber, M Westerman, N Leviatan-Strauss, M Hochberg, Increased Prevalence of Onychomycosis among Psoriatic Patients in Israel Acta Dermato-venereologica. ,vol. 88, pp. 31- 33 ,(2008) , 10.2340/00015555-0323